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Hypertensive risk factors in kidney disease in African Ameri- ated nephrosclerosis has been associated with genetically
cans. African Americans with hypertension more commonly and/or environmentally induced amplification of profi-
develop renal insufficiency compared to Caucasians. The Afri- brotic mechanisms, such as the renin-angiotensin systemcan American Study of Kidney Disease (AASK) included a re-
(RAS) and transforming growth factor- (TGF-) [10–13].nal biopsy pilot study that demonstrated that the clinical diag-
The AASK study importantly confirmed that renalnosis of so-called hypertensive nephrosclerosis in these African
American patients indeed was accurate. This biopsy study dem- biopsies in African Americans with a clinical diagno-
onstrated extensive global glomerulosclerosis, far exceeding sis of hypertensive nephrosclerosis show morphological
that expected for patients’ age. We further compared our clini- lesions consistent with this diagnosis. The typical mor-cally indicated renal biopsies to determine if any phenotypic dif-
phologic features of hypertensive nephrosclerosis areferences were present in hypertensive nephrosclerosis in Afri-
vascular wall medial thickening with frequent arteriolarcan Americans versus Caucasians. These studies point to an
excess of the solidified type of global glomerulosclerosis (GS) hyaline deposits, a varying degree of intimal fibrosis and
(also called “decompensated benign nephrosclerosis”) in Afri- focal glomerular ischemic changes with variable thick-
can Americans compared to more obsolescent type GS in Cau-
ening and wrinkling of the basement membrane, and tu-casians. We speculate that these phenotypic differences might
bular atrophy and interstitial fibrosis, with varying footreflect differing mechanisms of tissue injury in hypertensive
African Americans versus Caucasians, and discuss possible process effacement. These changes of hypertensive neph-
contributors to this injury. rosclerosis were widespread in nearly all cases in the
AASK biopsy study [14]. The extent of arterio- and
arteriolosclerosis did not correlate with age in this study,
Hypertensive nephrosclerosis is one of the most com- supporting the thesis that a disease process rather than
mon causes of end-stage renal disease (ESRD) world- aging per se contributed to the changes. For obvious
wide [1, 2]. This incidence is especially high in the USA ethical reasons, a control population is not included in
in African Americans [2]. This difference cannot be ex- the AASK study. Therefore, we also studied our clinical
plained by the higher prevalence and greater severity renal biopsies to compare hypertensive nephrosclerosis
of hypertension in African Americans nor by socioeco- lesions in biopsied African Americans and Caucasians
nomic status, nor less access to health care [3, 4]. Despite [15]. Clearly, in this retrospective study, clinical criteria
similar blood pressure (BP), African Americans with hy- for renal biopsy determined the study population. Per-
pertension and renal insufficiency have a more rapid fall neger et al have elegantly demonstrated that the pre-
in renal function than Caucasians [5, 6], suggesting that sumptive, clinical diagnosis of hypertensive nephroscle-
a lower level of BP control may be even more important rosis is made much more commonly in African Americans
in African Americans than in Caucasians in slowing the than in Caucasians [16]. Therefore, it is expected that Afri-
progression of renal disease [7, 8]. Indeed, the recent up- can Americans with hypertensive and renal insufficiency
date on the AASK intervention trial showed that BP would only be biopsied when the clinical situation was
control with an angiotensin I converting enzyme (ACE)- atypical for hypertension nephrosclerosis or was more
inhibitor could slow progressive loss of the glomerular severe. All cases from our renal biopsy files with a clinico-
filtration rate (GFR) in African Americans with hyper- pathologic diagnosis of hypertension nephrosclerosis in
tensive nephrosclerosis [9]. Conversely, excess end organ the absence of other disease were reviewed. Cases with
damage in African Americans with hypertension-associ- hypertensive changes and in addition segmental glomer-
ulosclerosis lesions were included when primary FSGS
was excluded by usual diagnostic criteria. Sixty-two renalKey words: hypertensive nephrosclerosis, hypertension, race, global
glomerulosclerosis, AASK. biopsies met the criteria (19 African American and 43 Cau-
casian). Global glomerulosclerosis was classified as either 2003 by the International Society of Nephrology
S-17
Fogo: Hypertensive nephrosclerosis and raceS-18
solidified or obsolescent type. Obsolescent glomeruli merulosclerosis in African American patients with hyper-
tensive nephrosclerosis? We speculate that the coexistencewere defined as glomeruli in which Bowman’s space was
occupied by collagenous, periodic acid Schiff (PAS)-pos- of solidified glomeruli with segmental glomerulosclerosis
could reflect an increased vasoreactivity in susceptibleitive material, and the tuft was retracted, as first de-
scribed by McManus in 1960 as “ischemic obsolescence” populations. African Americans tend to show a larger in-
crease in blood pressure level than Caucasians during[17]. Solidified glomeruli were defined as glomeruli in
which the entire tuft was solidified, in the absence of the stress, particularly to stimuli that elicit a vasoconstrictor
response [20–22]. Autoregulatory responses to hyperten-collagenous change in the capsular space, as described
first by Fahr in 1925, and subsequently revisited by Bohle sion, resulting in vasospasm, could be excessive in patients
susceptible to developing hypertension, as is the case inand Ratschek, using the term “decompensated benign
nephrosclerosis” [18, 19]. some African Americans [23]. Thus, we speculate that
global vasoconstrictive ischemia could result in completeThe patients in this retrospective analysis were on
average 58.7 2.0 years. African Americans were younger collapse and solidification. Further, we hypothesize that
adaptation and segmental resistance to collapse and/orthan Caucasians, and had higher serum creatinine values.
Proteinuria and hypertension were similar in the two reflow, with possible attendant segmental hypertension/
hyperfiltration, could give rise to segmental sclerotic le-populations. Total global glomerular sclerosis was exten-
sive in both African Americans and Caucasians (all pa- sions associated with solidification in those patients. Thus,
vasospasm could reflect primary microvascular injurytients 42  3%; African Americans 50  5% vs. Cauca-
sians 39  4%, P  NS). This severity of overall global and endothelial dysfunction that then cause hyperten-
sion, or occur in response to hypertension in susceptibleglomerulosclerosis was similar to that seen in the AASK
biopsy study, where patients on average were aged patients. It is possible that a primary renal microvascular
disease results in hypertension, glomerulosclerosis, and53.0  11.0 years, and had on average 43  26% global
glomerulosclerosis [14]. Surprisingly, the percent of so- interstitial fibrosis [4].
In regards to a possible role of hypertension in thelidified glomeruli was significantly increased in African
Americans (all patients 13  2%; African Americans lesions, Kincaid-Smith has noted that blood vessels in
benign nephrosclerosis “do not show the type of lesions25  6% vs. Caucasians 8  2%, P  0.01). In contrast,
the percent of obsolescent glomeruli was not different which deprives nephrons of their blood supply” [24].
Interestingly, even in non-hypertensive renal disease, sig-between African-Americans and Caucasians (all patients
29  3%; African Americans 24  5% vs. Caucasians nificant vascular sclerosis was present in the majority of
patients in a large renal biopsy series. The most severe31  4%, P  NS). The percent of solidified glomeruli
did not increase with aging, while the percent of obsoles- vascular sclerosis was present in patients with focal seg-
mental glomerulosclerosis (FSGS), followed by membra-cent glomeruli did. Solidified glomeruli were associated
with segmental glomerulosclerosis, and with clinically nous glomerulopathy, and IgA nephropathy. Surpris-
ingly, 76.5% of patients with chronic interstitial nephritisworse disease.
A multiple linear regression analysis was performed showed vascular sclerosis, with no difference in sclerosis
in those with hypertension versus those with normalto examine if the clinical parameters of proteinuria, mean
arterial pressure (MAP), serum creatinine and age could blood pressure, implicating injury mechanisms other
than systemic hypertension in this lesion [25].predict the severity of structural injury observed. Of
note, total global sclerosis and vascular sclerosis were Vascular sclerosis and glomerulosclerosis increase in
normal populations with aging, but the rate varies widelypoorly predicted by this model (R2  0.16). MAP did
not contribute to the prediction by the model of any in different populations. The extent of global sclerosis
in normal adults under the age of 50 years is estimatedmorphologic lesions, and proteinuria accounted only
minimally for the variability of global glomerulosclerosis. to be 1 to 3% of glomeruli, increasing up to 30% by age
80 years in the USA [26, 27]. The Mexican populationIn summary, in this study, age and blood pressure were
not good predictors of the severity of structural injuries. showed less aortic fibroplasia and renal sclerosis at all
ages compared to the US population [28]. First and sec-Previously, analysis of the AASK data also showed that
the extensive global glomerulosclerosis (which has not ond generation Hispanic immigrants to the USA had
increasing renal vascular sclerosis to intermediate levelsyet been analyzed in terms of specific type of GS) did not
correlate with vascular thickening, nor did the vascular between Mexico City natives and other USA residents
[29]. In a similar morphologic study of Bolivian Indians,lesions correlate with the degree of hypertension [19].
Thus, both our retrospective biopsy study and the AASK only minimal vessel wall changes occurred with aging,
even up to 80 years [30]. Elderly Japanese hypertensiverenal biopsy data do not support a simple linear relation-
ship between hypertension, vascular sclerosis, and ulti- patients showed only minimal glomerulosclerosis, even
less than expected for age in the USA Caucasian popula-mately global glomerulosclerosis.
What then could account for the extensive global glo- tion [31, 32]. Within the USA, vessel wall thickening in-
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creased with age in African Americans and was even subsequent renal and vascular sclerosis in adulthood
could thus be linked to polymorphisms that also resultmore severe than in the Caucasian population [33].
Higher blood pressure was present in the African Ameri- in a developmental environment that affects glomerular
development and growth. The RAS is one of severalcan population compared to the Caucasians in the New
Orleans region examined in this study, but these differ- mediators with effects on both embryonic and matura-
tional development of the kidney, and response to injury.ences, if extrapolated to the autopsied patients in that
area, would not completely account for the greater vascu- Specific polymorphisms in angiotensin I converting en-
zyme (ACE), angiotensinogen, and the angiotensin typelar wall thickening in the African American population.
These observations point to possible differences between 1 receptor genes have been linked with cardiovascular
disorders, including hypertension, myocardial infarctionpopulations, both in “normal” aging and in response to
injury, suggesting both environmental and genetic contri- and cardiac hypertrophy [41]. Familial clustering of
chronic renal failure has been noted in African Ameri-butions to the manifestations of disease.
Low birth weight, defined as birth weight less than cans [3, 42], and angiotensinogen gene mutations were
increased in African Americans with essential hyperten-2.5 kg at term birth, may have both environmental and
genetic components. Low birth weight is more common sion, compared to Caucasian hypertensive populations
[12]. The insertion/deletion (I/D) polymorphism of thein African Americans than in Caucasians. A linkage of
low birth weight to lower nephron number has been ACE gene also has been studied extensively. The D
polymorphism has been associated with higher RAS ac-postulated to be a predictor of hypertension, cardiovas-
cular and renal disease in adulthood [34, 35]. The mecha- tivity, augmented response to angiotensin II, and pro-
gression [43]. This D allele is significantly more frequentnism has been hypothesized to involve greater hemody-
namic stress on the fewer nephrons. In addition, when in African American populations compared to Cauca-
sians [44, 45]. Interestingly, a study from Spain showednephrons are decreased in number, an increase in glo-
merular size, that is, glomerular hypertrophy, may occur. that hypertensive patients with impaired GFR more fre-
quently were homozygous DD, compared to normalGlomerular hypertrophy is a sensitive marker for patho-
genic processes that lead to sclerosis [36]. Thus, we found ACE genotype distribution in hypertensive patients with
preserved renal function [46].that in patients with apparent minimal change disease
who subsequently showed overt focal segmental glomer- Pharmacological inhibition of the RAS inhibits matu-
rational glomerular growth in animal models [47]. Angio-ulosclerosis on rebiopsy, glomerular size was markedly
larger than in age-matched patients with the typical tensinogen knockout mice have increased arteriosclero-
sis, despite low blood pressures, and also have decreasedcourse of steroid-resistant minimal change disease [37].
We therefore examined whether glomerular size differed glomerular maturation and hypoplastic papillae, point-
ing to a crucial role of the RAS in development [48].in normal African American and Caucasian populations
[38]. Data were gathered from age- and body mass index Excess RAS is equally deleterious to the kidney as its
absence, pointing to a crucial role for a finely balanced(BMI)-matched sudden/traumatic deaths in patients
without cardiovascular disease. Glomerular volume was local RAS in kidney development and injury. In trans-
genic mice with increased copy number of the ACE gene,significantly greater in African Americans versus Cauca-
sians, and the distribution pattern was different in the and thus increased RAS activity, abnormal structural
development, with small glomeruli and vascular sclerosis,two groups. The African American population showed
a Gaussian distribution of glomerular size. In contrast was also present [49]. The RAS also modulates the scle-
rosis that occurs in association with aging in experimentalthe Caucasian population had a bi-modal distribution,
with a subgroup with enlarged glomerular size compara- models: chronic angiotensin inhibition treatment even
regressed age related sclerosis in rats in glomeruli andble to that in the African American population [38].
One can hypothesize that these larger glomeruli reflect blood vessels [50].
In summary, renal biopsy data suggest that there maya decreased nephron number at birth. Of interest in
this regard are Spencer, Wang and Hoy’s findings of be differing phenotypes of glomerulosclerosis in African
Americans versus Caucasians. The precise mechanismsmarkedly low birth weight in the Australian Aboriginal
population, not accounted for by prematurity [39]. Stud- underlying the severe global glomerulosclerosis have not
been established. Potential mechanisms include decreasedies in Aboriginal patients with renal insufficiency have
revealed varied histopathology, with frequent lesions re- nephron number possibly related to genetically influenced
growth factor profiles that also could influence fibroticlated to previous infection. However, of note, marked
glomerular enlargement is present in those biopsies that responses in adulthood, abnormal acceleration of aging,
abnormal vasoreactivity or other primary microvascularshow sclerotic lesions [40].
Maturation and number of glomeruli could be influ- diseases. Whether altered genotypes for renin-angioten-
sin affect vascular/glomerular structure from the earliestenced by functional polymorphisms of genes involved
both in renal/glomerular development and in scarring stages in utero to aging in the hypertensive African
American population remains to be elucidated.mechanisms. Augmented fibrotic responses to injury and
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